Latest News

  • Biogen and Alkermes Announce License and Collaboration Agreement to Develop and Commercialize ALKS 8700 for the Treatment of Multiple Sclerosis Read More
  • Alkermes Named a Top Place to Work by The Boston Globe Read More
  • Alkermes’ New Drug Application for Investigational Product Designed for Initiation Onto ARISTADA® Accepted for Filing by U.S. FDA Read More

Investors

Working at Alkermes